BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 23364277)

  • 1. Epigenetic regulation of estrogen signaling in breast cancer.
    Hervouet E; Cartron PF; Jouvenot M; Delage-Mourroux R
    Epigenetics; 2013 Mar; 8(3):237-45. PubMed ID: 23364277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioactive dietary supplements reactivate ER expression in ER-negative breast cancer cells by active chromatin modifications.
    Meeran SM; Patel SN; Li Y; Shukla S; Tollefsbol TO
    PLoS One; 2012; 7(5):e37748. PubMed ID: 22662208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular action of the estrogen receptor and hormone dependency in breast cancer.
    Iwase H
    Breast Cancer; 2003; 10(2):89-96. PubMed ID: 12736560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen-induced hypomethylation and overexpression of YAP1 facilitate breast cancer cell growth and survival.
    Muhammad JS; Guimei M; Jayakumar MN; Shafarin J; Janeeh AS; AbuJabal R; Eladl MA; Ranade AV; Ali A; Hamad M
    Neoplasia; 2021 Jan; 23(1):68-79. PubMed ID: 33242831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology.
    Katzenellenbogen BS; Choi I; Delage-Mourroux R; Ediger TR; Martini PG; Montano M; Sun J; Weis K; Katzenellenbogen JA
    J Steroid Biochem Mol Biol; 2000 Nov; 74(5):279-85. PubMed ID: 11162936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional regulation of mixed lineage kinase 3 by estrogen and its implication in ER-positive breast cancer pathogenesis.
    Viswakarma N; Nair RS; Sondarva G; Das S; Ibrahimi L; Chen Z; Sinha S; Rana B; Rana A
    Oncotarget; 2017 May; 8(20):33172-33184. PubMed ID: 28388540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic mechanisms of cancer progression and therapy resistance in estrogen-receptor (ER+) breast cancer.
    Toska E
    Biochim Biophys Acta Rev Cancer; 2024 May; 1879(3):189097. PubMed ID: 38518961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen Receptor-β Modulation of the ERα-p53 Loop Regulating Gene Expression, Proliferation, and Apoptosis in Breast Cancer.
    Lu W; Katzenellenbogen BS
    Horm Cancer; 2017 Aug; 8(4):230-242. PubMed ID: 28577282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity-Altered Adipose Stem Cells Promote ER⁺ Breast Cancer Metastasis through Estrogen Independent Pathways.
    Sabol RA; Beighley A; Giacomelli P; Wise RM; Harrison MAA; O'Donnnell BA; Sullivan BN; Lampenfeld JD; Matossian MD; Bratton MR; Wang G; Collins-Burow BM; Burow ME; Bunnell BA
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30897853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The rearranged during transfection/papillary thyroid carcinoma tyrosine kinase is an estrogen-dependent gene required for the growth of estrogen receptor positive breast cancer cells.
    Wang C; Mayer JA; Mazumdar A; Brown PH
    Breast Cancer Res Treat; 2012 Jun; 133(2):487-500. PubMed ID: 21947652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen receptors: selective ligands, partners, and distinctive pharmacology.
    Katzenellenbogen BS; Montano MM; Ediger TR; Sun J; Ekena K; Lazennec G; Martini PG; McInerney EM; Delage-Mourroux R; Weis K; Katzenellenbogen JA
    Recent Prog Horm Res; 2000; 55():163-93; discussion 194-5. PubMed ID: 11036937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic oxidative stress causes estrogen-independent aggressive phenotype, and epigenetic inactivation of estrogen receptor alpha in MCF-7 breast cancer cells.
    Mahalingaiah PK; Ponnusamy L; Singh KP
    Breast Cancer Res Treat; 2015 Aug; 153(1):41-56. PubMed ID: 26208486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholesterol biosynthesis pathway as a novel mechanism of resistance to estrogen deprivation in estrogen receptor-positive breast cancer.
    Simigdala N; Gao Q; Pancholi S; Roberg-Larsen H; Zvelebil M; Ribas R; Folkerd E; Thompson A; Bhamra A; Dowsett M; Martin LA
    Breast Cancer Res; 2016 Jun; 18(1):58. PubMed ID: 27246191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of estrogen receptor signaling triggers epigenetic silencing of downstream targets in breast cancer.
    Leu YW; Yan PS; Fan M; Jin VX; Liu JC; Curran EM; Welshons WV; Wei SH; Davuluri RV; Plass C; Nephew KP; Huang TH
    Cancer Res; 2004 Nov; 64(22):8184-92. PubMed ID: 15548683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CHRNA5 belongs to the secondary estrogen signaling network exhibiting prognostic significance in breast cancer.
    Shehwana H; Keskus AG; Ozdemir SE; Acikgöz AA; Biyik-Sit R; Cagnan I; Gunes D; Jahja E; Cingir-Koker S; Olmezer G; Sucularli C; Konu O
    Cell Oncol (Dordr); 2021 Apr; 44(2):453-472. PubMed ID: 33469842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global identification of genes regulated by estrogen signaling and demethylation in MCF-7 breast cancer cells.
    Putnik M; Zhao C; Gustafsson JÅ; Dahlman-Wright K
    Biochem Biophys Res Commun; 2012 Sep; 426(1):26-32. PubMed ID: 22902638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. H4K12ac is regulated by estrogen receptor-alpha and is associated with BRD4 function and inducible transcription.
    Nagarajan S; Benito E; Fischer A; Johnsen SA
    Oncotarget; 2015 Mar; 6(9):7305-17. PubMed ID: 25788266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct regulation of microRNA biogenesis and expression by estrogen receptor beta in hormone-responsive breast cancer.
    Paris O; Ferraro L; Grober OM; Ravo M; De Filippo MR; Giurato G; Nassa G; Tarallo R; Cantarella C; Rizzo F; Di Benedetto A; Mottolese M; Benes V; Ambrosino C; Nola E; Weisz A
    Oncogene; 2012 Sep; 31(38):4196-206. PubMed ID: 22231442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Williams syndrome transcription factor (WSTF) acts as an activator of estrogen receptor signaling in breast cancer cells and the effect can be abrogated by 1α,25-dihydroxyvitamin D
    Lundqvist J; Kirkegaard T; Laenkholm AV; Duun-Henriksen AK; Bak M; Feldman D; Lykkesfeldt AE
    J Steroid Biochem Mol Biol; 2018 Mar; 177():171-178. PubMed ID: 28610873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel combinatorial approach using sulforaphane- and withaferin A-rich extracts for prevention of estrogen receptor-negative breast cancer through epigenetic and gut microbial mechanisms.
    Rahman MM; Wu H; Tollefsbol TO
    Sci Rep; 2024 May; 14(1):12091. PubMed ID: 38802425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.